BioRem Inc. (TSXV:BRM)

BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 30.86 million. The enterprise value is 26.34 million.

Market Cap	30.86M
Enterprise Value	26.34M

Important Dates

The next estimated earnings date is Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

BioRem has 16.07 million shares outstanding. The number of shares has decreased by -6.76% in one year.

Current Share Class	16.07M
Shares Outstanding	16.07M
Shares Change (YoY)	-6.76%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	2.01%
Owned by Institutions (%)	n/a
Float	15.75M

Valuation Ratios

The trailing PE ratio is 11.82 and the forward PE ratio is 8.93.

PE Ratio	11.82
Forward PE	8.93
PS Ratio	0.80
PB Ratio	2.82
P/TBV Ratio	2.82
P/FCF Ratio	6.98
P/OCF Ratio	6.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.25, with an EV/FCF ratio of 5.96.

EV / Earnings	8.38
EV / Sales	0.69
EV / EBITDA	5.25
EV / EBIT	5.92
EV / FCF	5.96

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.29.

Current Ratio	1.73
Quick Ratio	1.45
Debt / Equity	0.29
Debt / EBITDA	0.63
Debt / FCF	0.71
Interest Coverage	25.03

Financial Efficiency

Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 21.52%.

Return on Equity (ROE)	33.38%
Return on Assets (ROA)	10.81%
Return on Invested Capital (ROIC)	21.52%
Return on Capital Employed (ROCE)	33.18%
Revenue Per Employee	1.13M
Profits Per Employee	92,491
Employee Count	34
Asset Turnover	1.49
Inventory Turnover	14.71

Taxes

In the past 12 months, BioRem has paid 1.14 million in taxes.

Income Tax	1.14M
Effective Tax Rate	26.63%

Stock Price Statistics

The stock price has decreased by -25.58% in the last 52 weeks. The beta is 0.71, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-25.58%
50-Day Moving Average	2.02
200-Day Moving Average	2.24
Relative Strength Index (RSI)	41.03
Average Volume (20 Days)	21,471

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 38.36 million and earned 3.14 million in profits. Earnings per share was 0.16.

Revenue	38.36M
Gross Profit	10.28M
Operating Income	4.45M
Pretax Income	4.29M
Net Income	3.14M
EBITDA	4.83M
EBIT	4.45M
Earnings Per Share (EPS)	0.16

Balance Sheet

The company has 7.66 million in cash and 3.14 million in debt, giving a net cash position of 4.52 million or 0.28 per share.

Cash & Cash Equivalents	7.66M
Total Debt	3.14M
Net Cash	4.52M
Net Cash Per Share	0.28
Equity (Book Value)	10.94M
Book Value Per Share	0.68
Working Capital	10.02M

Cash Flow

In the last 12 months, operating cash flow was 4.76 million and capital expenditures -345,113, giving a free cash flow of 4.42 million.

Operating Cash Flow	4.76M
Capital Expenditures	-345,113
Free Cash Flow	4.42M
FCF Per Share	0.27

Margins

Gross margin is 26.79%, with operating and profit margins of 11.60% and 8.20%.

Gross Margin	26.79%
Operating Margin	11.60%
Pretax Margin	11.17%
Profit Margin	8.20%
EBITDA Margin	12.58%
EBIT Margin	11.60%
FCF Margin	11.52%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.76%
Shareholder Yield	6.76%
Earnings Yield	10.19%
FCF Yield	14.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 3.95 and a Piotroski F-Score of 7.

Altman Z-Score	3.95
Piotroski F-Score	7